Gain Therapeutics Companies
By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding, including lysosomal storage disorders.
Industry:
AI for Longevity
Headquarters:
Bethesda, Maryland, United States
Founded Date:
Jan 2017
Register and Claim Ownership